Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00066859 · ClinicalTrials.gov registry record · Phase 3
Sertraline Compared With Hypericum Perforatum (St.John's Wort) in Treating Depression
A Phase 3 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 3
- Development phase
- 2
- Enrollment target
NCT00066859 is a Phase 3 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 2 participants.
The verdict
NCT00066859, a Phase 3 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2 participants
- Enrollment target
Study Summary
RATIONALE: Antidepressants such as sertraline and the herb hypericum perforatum (St. John's wort) may be effective in treating mild to moderate depression. It is not yet known which treatment is more effective in improving depression in patients who have cancer. PURPOSE: This randomized phase III trial is studying how well sertraline works compared to St. John's wort in treating mild to moderate depression in patients with solid tumors.
Interventions
- DRUG Zoloft 50 mg
- DIETARY_SUPPLEMENT St. John's Wort 600 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2004-03-01 |
| Est. Completion | 2005-11-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00066859
The ClinicalTrials.gov registry entry for NCT00066859 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Zoloft 50 mg is the first listed.
NCT00066859 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00066859 about?
NCT00066859 is a clinical study titled "Sertraline Compared With Hypericum Perforatum (St.John's Wort) in Treating Depression". RATIONALE: Antidepressants such as sertraline and the herb hypericum perforatum (St. John's wort) may be effective in treating mild to moderate depression. It is not yet known which treatment is more effective in improving depression in patients who have cancer. PURPOSE: This randomized phase III t...
What is the current status of trial NCT00066859?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2 participants. The study started on 2004-03-01. Estimated completion is 2005-11-01.
What interventions are being tested in trial NCT00066859?
The interventions under investigation include: Zoloft 50 mg (DRUG), St. John's Wort 600 mg (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00066859?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.